Fixed-Bed MDA Hydrogenation for PACM Isomer Ratio Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hydrogenation processes for producing methylenebis(cyclohexylamine) face challenges in achieving defined proportions of isomers and are inefficient in terms of product conversion and energy usage, particularly in producing products with low trans/trans content, which are essential for specific applications such as amine and isocyanate crosslinkers and polyamide compounds.

Innovation Solution

A plant and process for continuous catalytic hydrogenation of methylenedianiline using a fixed bed reactor with a separate flow pathway for heat exchange medium, incorporating a heat exchanger and a media circuit with multiple stages for efficient heat management and isomer control, allowing for precise adjustment of isomer ratios through temperature control in multiple reactors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If hydrogenation is performed to produce methylenebis(cyclohexylamine) with low trans/trans content, then product quality for specific applications is improved, but energy consumption increases and product conversion efficiency decreases

Engineering Contradiction:
Improveisomer ratio controlVSAvoidenergy consumption
Core Design Contradiction:
Manufacturing precisionVSUse of energy by moving object

Solution Approach 1:

The hydrogenation process is divided into multiple sequential reaction stages, each with independently controllable temperature and residence time. This segmentation allows optimization of each stage for specific isomer formation, enabling precise control of trans/trans content while reducing overall energy consumption compared to single-stage processes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The process employs dynamic temperature control across multiple reactor stages, adjusting temperature profiles to favor formation of desired isomers at different stages. This dynamic approach enables production of low trans/trans content products with improved energy efficiency by avoiding excessive temperature requirements.

Inventive Principle:
Principle #15Dynamics

2Manufacturing precision

If hydrogenation is performed to produce methylenebis(cyclohexylamine) with low trans/trans content, then product quality for specific applications is improved, but productivity decreases

Engineering Contradiction:
Improveisomer ratio controlVSAvoidproduct conversion efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The hydrogenation process is divided into multiple sequential reaction stages, each with independently controllable temperature and residence time. This segmentation allows optimization of each stage for specific isomer formation, enabling precise control of trans/trans content while reducing overall energy consumption compared to single-stage processes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The process employs dynamic temperature control across multiple reactor stages, adjusting temperature profiles to favor formation of desired isomers at different stages. This dynamic approach enables production of low trans/trans content products with improved energy efficiency by avoiding excessive temperature requirements.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If conventional hydrogenation processes are used, then simplicity of process is maintained, but energy efficiency is poor and isomer control is insufficient

Engineering Contradiction:
Improveprocess simplicityVSAvoidenergy efficiency
Core Design Contradiction:
Device complexityVSLoss of energy

Solution Approach 1:

The hydrogenation process is divided into multiple sequential reaction stages, each with independently controllable temperature and residence time. This segmentation allows optimization of each stage for specific isomer formation, enabling precise control of trans/trans content while reducing overall energy consumption compared to single-stage processes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The process employs continuous operation through multiple sequential reactor stages with integrated heat exchange systems. This continuous action minimizes energy losses and maintains optimal conditions for isomer formation throughout the reaction sequence, improving overall energy efficiency while controlling product distribution.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process enables the production of methylenebis(cyclohexylamine) with controlled isomer ratios, improving product conversion and energy efficiency by minimizing unwanted by-products and reducing energy costs, thus meeting the requirements of different application needs.

Implementation Method 1

continuous catalytic hydrogenation of methylenedianiline with a hydrogen donor

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

hydrogenation of MDA is highly exothermic

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 3

at least one heat exchanger in at least one (feed) conduit

Methodology Applied
Scientific EffectHeat transfer: Heat Exchanger

Implementation Method 4

Hydrogenation of MDA is highly exothermic. For example, WO 2010/069484 A1 indicates an enthalpy of reaction of −1600 KJ/mol

Methodology Applied
Scientific EffectExothermic reaction: Exothermic Reaction

Data Source

PatentUS20260027536A1Process for continuous catalytic hydrogenation of mda
Publication Date: 2026.01.29 EVONIK OPERATIONS GMBH
  • US20260027536A1 patent drawing
  • US20260027536A1 patent drawing
  • US20260027536A1 patent drawing

AI summary

A plant for continuous catalytic hydrogenation of methylenedianiline (MDA; reactant1) with a hydrogen donor (reactant2), especially a gaseous hydrogen donor, preferably hydrogen (H2), including a conditioning unit for the reactants, a reactor unit for synthesis of PACM, and a separation unit, wherein the conditioning unit includes at least part of the length of the (feed) conduits for reactant1, reactant2 and at least one solvent, at least one heat exchanger in at least one (feed) conduit, at least one mixer for mixing the reactants and/or at least one reactant with at least one solvent; the reactor unit includes at least one fixed bed reactor as main reactor with an immobile catalyst packing.